Wang De-chen, Song Shi-bing, Yuan Jiong, Xiu Dian-rong, Zhu Jian-ping, Jiang Bin, Zhang Tong-lin
Department of General Surgery, Third Hospital of Peking University, Beijing 100083, China.
Zhonghua Zhong Liu Za Zhi. 2003 May;25(3):295-7.
To investigate the value of liver transplantation for late hepatocellular carcinoma.
Thirty-six patients were treated by liver transplantation from August 2000 to February 2002, of which 15 patients had had advanced hepatocellular carcinoma and thirteen of these 15 patients were evaluated for results.
The 1-year survival rate was 86% (6/7). Only one patient died of recurrence within 6 months. The tumor-free survival was 5 to 19 months. Till February 2002, two patients have survived for 10 months and 19 months with recurrence.
In our country, if the patients can afford liver transplantation, advanced hepatocellular carcinoma without extrahepatic metastasis is still indicated for liver transplantation, since some patients may survive relatively long.
探讨肝移植治疗晚期肝细胞癌的价值。
2000年8月至2002年2月期间，36例患者接受了肝移植治疗，其中15例患有晚期肝细胞癌，这15例患者中的13例接受了疗效评估。
1年生存率为86%（6/7）。仅1例患者在6个月内死于复发。无瘤生存期为5至19个月。至2002年2月，2例患者分别存活了10个月和19个月且出现了复发。
在我国，如果患者能够负担得起肝移植费用，无肝外转移的晚期肝细胞癌仍可考虑行肝移植治疗，因为部分患者可能存活较长时间。
